Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Clinical Trial Calendar
Results Date
Company Name
Ticker
Event
Indication
Outcome
29-May-2026 To 02-Jun-2026
OS Therapies Inc.
OSTX
2.5-year overall survival data of OST-HER2
Prevention or delay of recurrence in fully-resected, pulmonary metastatic osteosarcoma
31-May-2026
Agenus Inc.
AGEND
,
AGEN
Full data from Phase 2 study of botensilimab in combination with balstilimab (C-800-23)
Advanced cutaneous melanoma refractory or resistant to prior anti-PD-(L)1 therapy
04-Jun-2026
Zenas BioPharma, Inc.
ZBIO
Safety and efficacy results from Phase 3 trial of obexelimab (INDIGO)
Immunoglobulin G4-Related Disease (IgG4-RD)
25-Jun-2026 To 27-Jun-2026
Transgene SA
TRGNF
, TNG.PA
Preclinical data of TG-MVA
mpox Vaccine
Buy this Content
Editors Pick
Dollar Tree Stock Up 13% On Q1 Results, Positive Outlook, Deal With DoorDash
May 28, 2026 08:13 ET
DICK'S Sporting Cuts FY26 Earnings View, Backs Adj. EPS, Sales Forecast After Q1 Growth; Stock Down
May 27, 2026 09:46 ET
French Court Rules Air France And Airbus Guilty In 2009 Plane Crash; Companies To Appeal
May 22, 2026 05:33 ET
Walmart Sees Growth In Q2, Backs FY27 Outlook After Strong Q1; Stock Down
May 21, 2026 08:33 ET